US4075335A
(en)
*
|
1972-08-24 |
1978-02-21 |
Ciba-Geigy Corporation |
Pharmaceutical piperidine derivatives
|
US3956335A
(en)
*
|
1972-08-24 |
1976-05-11 |
Ciba-Geigy Corporation |
1-Substituted-4-(2-oxo-1-imidazolidinyl) piperidines
|
US3996362A
(en)
*
|
1975-05-28 |
1976-12-07 |
E. R. Squibb & Sons, Inc. |
2-[[4-(2,3-Dihydro-2-oxo-1H-benzimidazol-1-yl)-1-(piperidinyl or 1,2,3,6-tetrahydro-1-pyridinyl)]alkyl]-1H-benz[de]isoquinoline-1,3(2H)-diones
|
US3963727A
(en)
*
|
1975-06-06 |
1976-06-15 |
Daiichi Seiyaku Co., Ltd. |
1,2 Disubstituted benzimidazole derivatives
|
US4066772A
(en)
*
|
1975-07-21 |
1978-01-03 |
Janssen Pharmaceutica N.V. |
1,3-Dihydro-1-[3-(1-piperidinyl)propyl]-2H-benzimidazol-2-ones and related compounds
|
JPS54160371A
(en)
*
|
1978-06-02 |
1979-12-19 |
Kyowa Hakko Kogyo Co Ltd |
Novel piperidine derivative and hypotensive agents comprising it
|
US4200755A
(en)
*
|
1979-05-04 |
1980-04-29 |
Richardson-Merrell Inc. |
2-Hydroxy-5-[1-hydroxy-2-[4-(2-oxo-1-benzimidazolinyl)piperidino]ethyl]benzoic acid derivatives
|
US4264613A
(en)
*
|
1979-08-01 |
1981-04-28 |
Science Union Et Cie, Societe Francaise De Recherche Medicale |
Piperidylbenzimidazolinone compounds
|
AU2388697A
(en)
*
|
1996-04-19 |
1997-11-12 |
Neurosearch A/S |
1-(4-piperidyl)-benzimidazoles having neurotrophic activity
|
PT1049689E
(pt)
|
1998-01-19 |
2002-09-30 |
Pfizer |
Compostos de 4-(2-ceto-1-benzimidazolinil)piperidina como agonistas do receptor orl1
|
ID29137A
(id)
*
|
1998-07-27 |
2001-08-02 |
Schering Corp |
Ligan-ligan afinitas tinggi untuk reseptor nosiseptin orl-1
|
US6262066B1
(en)
|
1998-07-27 |
2001-07-17 |
Schering Corporation |
High affinity ligands for nociceptin receptor ORL-1
|
MA26659A1
(fr)
*
|
1998-08-06 |
2004-12-20 |
Pfizer |
Dérivés de benzimidazole nouveaux, compositions pharmaceutiques les contenant et procédé pour leur préparation.
|
SE9903544D0
(sv)
*
|
1999-10-01 |
1999-10-01 |
Astra Pharma Prod |
Novel compounds
|
DE60022226D1
(de)
*
|
1999-12-06 |
2005-09-29 |
Euro Celtique Sa |
Benzimidazolverbindungen die nociceptinrezeptoraffinität haben
|
JP3989247B2
(ja)
|
1999-12-06 |
2007-10-10 |
ユーロ−セルティーク エス.エイ. |
ノシセプチン受容体親和性を有するトリアゾスピロ化合物
|
EP1244437A4
(fr)
|
1999-12-06 |
2005-02-09 |
Euro Celtique Sa |
Composes amino tertiaires presentant une affinite pour le recepteur opioide
|
DE60023100T2
(de)
|
2000-01-05 |
2006-07-06 |
Pfizer Inc. |
Benzimidazol-Verbindungen zur Verwendung als ORL1-Rezeptor-Antagonisten
|
GB2359081A
(en)
|
2000-02-11 |
2001-08-15 |
Astrazeneca Uk Ltd |
Pharmaceutically active thiazolopyrimidines
|
GB2359078A
(en)
*
|
2000-02-11 |
2001-08-15 |
Astrazeneca Uk Ltd |
Pharmaceutically active pyrimidine derivatives
|
GB2359551A
(en)
*
|
2000-02-23 |
2001-08-29 |
Astrazeneca Uk Ltd |
Pharmaceutically active pyrimidine derivatives
|
GB0005642D0
(en)
*
|
2000-03-10 |
2000-05-03 |
Astrazeneca Uk Ltd |
Chemical compounds
|
SE519954C2
(sv)
*
|
2000-08-09 |
2003-04-29 |
Elster Messtechnik Gmbh |
Anordning och förfarande för beröringsfri avkänning av en rotors rotationstillstånd
|
SE0003828D0
(sv)
*
|
2000-10-20 |
2000-10-20 |
Astrazeneca Ab |
Novel compounds
|
AU2002243419A1
(en)
*
|
2000-10-27 |
2002-07-24 |
Ortho-Mcneil Pharmaceutical, Inc. |
Substituted benzimidazol-2-ones as vasopressin receptor antagonists and neuropeptide y modulators
|
SE0101322D0
(sv)
*
|
2001-04-12 |
2001-04-12 |
Astrazeneca Ab |
Novel compounds
|
RU2299883C2
(ru)
|
2001-04-18 |
2007-05-27 |
Эро-Селтик, С.А. |
Соединения спиропиразола, содержащая их фармацевтическая композиция, способ модуляции опиоидного рецептора и способ лечения с применением таких соединений
|
CA2443938C
(fr)
|
2001-04-18 |
2010-06-22 |
R. Richard Goehring |
Composes de spiroindene et de spiroindane comme ligands opioides utiles pour le traitement de la douleur
|
SI1385518T1
(sl)
|
2001-04-18 |
2009-02-28 |
Euro Celtique Sa |
Benzimidazolonske spojine
|
EP1598339B1
(fr)
*
|
2001-04-18 |
2009-06-24 |
Euro-Celtique S.A. |
Derivés de la 1-(4-amino-cyclohexyl)-1,3-dihydro-2h-benzimidazole-2-one et composés similaires pour l'utilisation comme analogues du nociceptin et ligandes du orl1 pour le traitement de la douleur
|
BR0209128A
(pt)
*
|
2001-04-18 |
2005-11-01 |
Euro Celtique Sa |
Compostos, composições farmacêuticas, métodos para o tratamento de dores, métodos para a modulação de uma resposta farmacológica e usos de compostos
|
SE0102716D0
(sv)
*
|
2001-08-14 |
2001-08-14 |
Astrazeneca Ab |
Novel compounds
|
GB0221828D0
(en)
*
|
2002-09-20 |
2002-10-30 |
Astrazeneca Ab |
Novel compound
|
GB0221829D0
(en)
*
|
2002-09-20 |
2002-10-30 |
Astrazeneca Ab |
Novel compound
|
GB0328243D0
(en)
*
|
2003-12-05 |
2004-01-07 |
Astrazeneca Ab |
Methods
|
WO2007085357A1
(fr)
*
|
2006-01-30 |
2007-08-02 |
Euro-Celtique S.A. |
Composes cyclo-uree utilises en tant que bloqueurs des canaux calciques
|
WO2017161017A1
(fr)
|
2016-03-15 |
2017-09-21 |
The Scripps Research Institute |
Agonistes du récepteur opioïde mu à signalisation biaisée
|